These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. The angiotensin II type 1 receptor blocker valsartan attenuates graft vasculopathy. Yamamoto T; Sata M; Fukuda D; Takamoto S Basic Res Cardiol; 2005 Jan; 100(1):84-91. PubMed ID: 15490202 [TBL] [Abstract][Full Text] [Related]
14. Transplant atherosclerosis: the clinical syndrome, pathogenesis and possible model of spontaneous atherosclerosis. Fyfe AI Can J Cardiol; 1992 Jun; 8(5):509-19. PubMed ID: 1319812 [TBL] [Abstract][Full Text] [Related]
15. Accelerated coronary atherosclerosis in the allograft heart. Gravanis MB Postgrad Med J; 1994; 70 Suppl 1():S93-8. PubMed ID: 7971656 [No Abstract] [Full Text] [Related]
16. Injury of the coronary endothelium at implantation increases endothelial dysfunction and intimal hyperplasia after heart transplantation. El-Hamamsy I; Stevens LM; Vanhoutte PM; Perrault LP J Heart Lung Transplant; 2005 Mar; 24(3):251-8. PubMed ID: 15737750 [TBL] [Abstract][Full Text] [Related]
17. Coronary angioscopy in the diagnosis of graft coronary artery disease in heart transplant recipients. Ventura HO; White CJ; Ramee SR; Collins TJ; Mesa JE; Jain A J Heart Lung Transplant; 1991; 10(3):488. PubMed ID: 1854778 [No Abstract] [Full Text] [Related]
18. Heat shock protein 27 is associated with freedom from graft vasculopathy after human cardiac transplantation. De Souza AI; Wait R; Mitchell AG; Banner NR; Dunn MJ; Rose ML Circ Res; 2005 Jul; 97(2):192-8. PubMed ID: 15976317 [TBL] [Abstract][Full Text] [Related]